Rani Therapeutics shifts Nasdaq listing to Capital Market, gets more time on bid price
Nasdaq granted Rani an additional 180 days, until May 10, 2027, to regain compliance with the $1.00 minimum bid price rule after transferring its listing.
SEC filing